AML With Gene Mutations
2 clinical trials · Condition
◉ Watch AML With Gene Mutations
| Record | Firm | Date |
|---|---|---|
| Revumenib in Combination With 7+3 + Midostaurin in AML (NCT06313437) | Richard Stone, MD | 2024-12-06 |
| Dose Escalation and Expansion Study to Evaluate the Safety, PK, PD and Efficacy of ZE46-0134 in Adults With FLT3 Mutated or Spliceosome Mutated Relapsed or Refractory Acute Myeloid Leukemia (NCT06366789) | Lomond Therapeutics Holdings, Inc. | 2024-05-29 |
Track AML With Gene Mutations automatically
Every clearance here is in the API, with alerts when new ones post.